Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Modified cells of the mononuclear phagocyte system over-expressing neutrophil gelatinase-associated lipocalin can be used to prevent and treat ischemia, acute failure and transplant rejection by reducing inflammation and promoting tissue regeneration More
Collagen-based dressings for wound management More
Collagen-based biodegradable matrices for localized drug delivery More
Related Reports
Market Research Reports provided by reports.iptechex.com
Jun 2006 - 952 pages - $2,495
May 2011 - 15 pages - $250
Oct 2010 - 72 pages - $3,500
Mar 2011 - 31 pages - $1,000
Aug 2011 - 185 pages - $2,500
Mar 2011 - 85 pages - $3,500
Aug 2011 - 7 pages - $75
Aug 2011 - 7 pages - $75
Nov 2011 - 7 pages - $75
Jul 2009 - 134 pages - $3,500
Your selection
Browse By
- Industry sector
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Pharmaceutical
- Research tools
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us